Modeling the Blood-Brain Barrier Using Human-Induced Pluripotent Stem Cells

Area of Science:

• Neuroscience
• Stem Cell Biology
• Drug Discovery

Background:

• The blood-brain barrier (BBB) protects the brain but hinders drug delivery, with over 98% of therapeutics unable to cross.
• BBB dysfunction is implicated in neurodegenerative diseases like Alzheimer's and Parkinson's, yet its mechanisms are poorly understood due to limited human tissue access.

Purpose of the Study:

• To develop a novel in vitro model of the human blood-brain barrier (iBBB) using induced pluripotent stem cells.
• To provide a platform for investigating BBB formation, maintenance, and disease-related degeneration.
• To facilitate the discovery of disease mechanisms, drug targets, and optimize the development of central nervous system therapeutics.

Main Methods:

• Generation of an induced human blood-brain barrier (iBBB) model from pluripotent stem cells.
• Differentiation of endothelial cells, pericytes, and astrocytes from induced pluripotent stem cells.
• Assembly of differentiated cells into a functional iBBB model.

Main Results:

• Successfully developed an in vitro induced human blood-brain barrier (iBBB) model.
• Established a method to differentiate and assemble the three key cellular components of the BBB from iPSCs.
• Created a viable model for studying BBB in neurological diseases and for drug development.

Conclusions:

• The iBBB model offers a valuable tool for understanding BBB biology and its role in neurological disorders.
• This model system can accelerate the screening and optimization of brain-penetrating drugs.
• Further research using the iBBB model can lead to improved treatments for CNS diseases.